• Home
  • Caregen Co.,Ltd.
  • Korglutide: A Novel Breakthrough Sema/Liraglutide Replacement Oral Peptide for Weight Loss
Video
23 Oct 2024

Korglutide: A Novel Breakthrough Sema/Liraglutide Replacement Oral Peptide for Weight Loss

Clinical Approaches in Type 2 diabetes, Weight loss, and Fatty Liver Disease(NASH)

Content provided by our supplier

Caregen Co.,Ltd.

  • Country/Region:
    Korea, Republic Of
  • Founded:
    2001
  • On CPHI since:
    2016
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
Consumer Goods
Distributor/Import Export
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
OTC
Other
Primary activities
API Producer
Biopharmaceutical
Cosmeceuticals
Cosmetic Ingredients
Nutraceuticals
OTC
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile

Other Content from Caregen Co.,Ltd. ()